Trial Profile
A phase I, open-label, dose escalation study to evaluate the safety, tolerability, and pharmacokinetics of weekly intravenous INNO-105 in adult patients with advanced solid malignancies
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2006
Price :
$35
*
At a glance
- Drugs Methionine enkephalin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors INNOVIVE Pharmaceuticals
- 03 Oct 2006 Status change
- 28 Dec 2005 New trial record.